Author

R. Berg

Observed name: Russell Berg

Institutions: Amgen (United States), University of California, Los Angeles

Observed institutions: Amgen (United States), University of California, Los Angeles

OpenAlex ID: A5113520333

Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: A randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa

2005 · John Glaspy, David Henry, et al. · European Journal of Cancer · 90

Final results of a phase 3, randomized, open-label study of darbepoetin alfa 200 mcg every 2 weeks (Q2W) versus epoetin alfa 40,000 U weekly (QW) in patients with chemotherapy-induced anemia (CIA)

2005 · J. Glaspy, R. Berg, et al. · Journal of Clinical Oncology · 9

Works count: 2

Citation count: 99

H-index: 2

I10-index: 1